Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: A meta-analysis, 1985-2010

被引:70
|
作者
Jayaprakash, Vijayvel [1 ,2 ]
Reid, Mary [3 ]
Hatton, Elizabeth [1 ,2 ]
Merzianu, Mihai [4 ]
Rigual, Nestor [5 ,9 ]
Marshall, James [6 ]
Gill, Steve [7 ]
Frustino, Jennifer [1 ,2 ,6 ]
Wilding, Gregory [8 ]
Loree, Thom [5 ]
Popat, Saurin [9 ]
Sullivan, Maureen [1 ,2 ]
机构
[1] Roswell Pk Canc Inst, Dept Dent, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, MFP, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
[4] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA
[5] Roswell Pk Canc Inst, Dept Head & Neck Surg, Buffalo, NY 14263 USA
[6] Roswell Pk Canc Inst, Div Canc Prevent & Populat Sci, Buffalo, NY 14263 USA
[7] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA
[8] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA
[9] SUNY Buffalo, Dept Otolaryngol, Buffalo, NY 14260 USA
关键词
Human papillomavirus; Oral epithelial dysplasia; Oral cancer; Oropharyngeal cancer; Oral precancerous lesion; Epithelial carcinogenesis; Meta-analysis; Prevalence; SQUAMOUS-CELL CARCINOMA; PROLIFERATIVE VERRUCOUS LEUKOPLAKIA; POLYMERASE-CHAIN-REACTION; HOMOLOGOUS DNA-SEQUENCES; ORGANIZER REGIONS AGNOR; IN-SITU HYBRIDIZATION; RISK-FACTOR; MICROINVASIVE CARCINOMA; PRECANCEROUS LESIONS; MALIGNANT LESIONS;
D O I
10.1016/j.oraloncology.2011.07.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus (HPV) types 16 and 18 are causally related to a sub-set of oral cavity and oropharyngeal squamous cell cancers. However, a clear estimate of the prevalence of HPV-16/18 in oral cavity and oropharyngeal dysplasia (OOPD) is not available. This literature review and meta-analysis was conducted to provide a prevalence estimate for HPV-16/18 in OOPD. Twenty-two studies that reported prevalence of HPV-16 and/or 18 in 458 OOPD lesions were analyzed. Meta-analysis was used to evaluate the prevalence of HPV-16/18 and logistic regression was used for stratified analysis by age, gender, and histological grade. The overall prevalence of HPV-16/18 in OOPD lesions was 24.5% [95% confidence interval (CI), 16.4-36.7%)]. The individual prevalence for HPV-16 alone was 24.4%. The prevalence of HPV-16/18 in oral cavity lesions alone was 25.3% (95% CI, 14.2-45.2%). The odds of detection of HPV-16/18 in dysplastic lesions in males were twice that of females [odds ratio (OR), 2.44]. HPV-16/18 were 3 times more common in dysplastic lesions (OR, 3.29; 95% CI, 1.95-5.53%) and invasive cancers (OR, 3.43; 95% CI, 2.07-5.69%), when compared to normal biopsies. There was no significant difference in HPV-16/18 rates between dysplastic lesions and cancers or between mild, moderate or severe dysplastic lesions. This meta-analysis provides a quantification of the prevalence of HPV types 16/18 in OOPD lesions. These results also support the assumption that HPV-16/18 infection occurs during the early phase of the oral cavity and oropharyngeal carcinogenesis. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1048 / 1054
页数:7
相关论文
共 50 条
  • [21] Oral Epithelial Dysplasia Grading Systems: A Systematic Review & Meta-Analysis
    Khoury, Zaid H.
    Sultan, Mohamed
    Sultan, Ahmed S.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2022, 30 (05) : 499 - 511
  • [22] Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions
    Wen, SM
    Tsuji, T
    Li, XW
    Mizugaki, Y
    Hayatsu, Y
    Shinozaki, F
    ANTICANCER RESEARCH, 1997, 17 (1A) : 307 - 311
  • [23] Association between Human Papillomavirus and Oral Cancer in Iranian Clinical Samples: A Meta-Analysis Review
    Haghshenas, Mohammad Reza
    Moosazadeh, Mahmood
    Taghiloo, Saeid
    Sattari, Sogol
    Valadan, Reza
    Mousavi, Tahoora
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2022, 51 (12) : 2688 - 2696
  • [24] Correlation of human papillomavirus 16 and 18 with cervical cancer and their diagnosis methods in Iranian women: A systematic review and meta-analysis
    Fani, Mona
    Mahmoodi, Pegah
    Emadzadeh, Maryam
    Avan, Amir
    Karimi, Ehsan
    Ferns, Gordon A.
    Rezayi, Majid
    Amiri, Iraj S.
    CURRENT PROBLEMS IN CANCER, 2020, 44 (01)
  • [25] Prevalence of Human Papillomavirus 16 in Esophageal Cancer Among the Chinese Population: a Systematic Review and Meta-analysis
    Zhang, Shao-Kai
    Guo, Lan-Wei
    Chen, Qiong
    Zhang, Meng
    Liu, Shu-Zheng
    Quan, Pei-Liang
    Lu, Jian-Bang
    Sun, Xi-Bin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (23) : 10143 - 10149
  • [26] Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: A diagnostic meta-analysis
    Govers, Tim M.
    Hannink, Gerjon
    Merkx, Matthias A. W.
    Takes, Robert P.
    Rovers, Maroeska M.
    ORAL ONCOLOGY, 2013, 49 (08) : 726 - 732
  • [27] Prognostic biomarkers for malignant progression of oral epithelial dysplasia: an updated systematic review and meta-analysis
    Turton, Natalie
    Payne, Karl
    Higginson, James
    Praveen, Prav
    Mehanna, Hisham
    Nankivell, Paul
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2024, 62 (05) : 415 - 425
  • [28] Human papillomavirus types among women infected with HIV:: a meta-analysis
    Clifford, Gary M.
    Goncalves, Maria Alice G.
    Franceschi, Silvia
    AIDS, 2006, 20 (18) : 2337 - 2344
  • [29] The association between human papillomavirus 16 and esophageal cancer in Chinese population: a meta-analysis
    Shao-Kai Zhang
    Lan-Wei Guo
    Qiong Chen
    Meng Zhang
    Shu-Zheng Liu
    Pei-Liang Quan
    Jian-Bang Lu
    Xi-Bin Sun
    BMC Cancer, 15
  • [30] Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype
    Iocca, Oreste
    Sollecito, Thomas P.
    Alawi, Faizan
    Weinstein, Gregory S.
    Newman, Jason G.
    De Virgilio, Armando
    Di Maio, Pasquale
    Spriano, Giuseppe
    Pardinas Lopez, Simon
    Shanti, Rabie M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (03): : 539 - 555